In addition, we observed that high mRNA expression of STAT1 indicated a better OS in grade III and stage III/IV ovarian cancer patients, but not in grade I/II and stage I/II ovarian cancer patients, suggesting that STAT1 is a favorable prognostic marker for ovarian cancer patients, especially for late stage and poor differentiation serous ovarian patients. Here, STAT1 is linked to ovarian carcinoma.